查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1987322

样品製备市场规模、份额、趋势和预测：按产品、应用、最终用户和地区划分，2026-2034 年

Sample Preparation Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2025年全球样品製备市场规模为91亿美元。展望未来，IMARC集团预测，该市场将以5.05%的复合年增长率从2026年增长至2034年，到2034年达到141.6亿美元。目前，北美市场主导地位，预计2025年将占30%的市场。该地区受益于许多因素，例如：强大的医药和生物技术研发基础设施、先进的基因组学和蛋白​​质组学主导的工作流程的广泛应用、越来越多的慢性疾病需要精准的分子诊断，以及众多大型生命科学公司和研究机构的聚集，这些公司和机构正在不断扩大其在样品製备市场的份额。

全球样品製备市场正经历持续成长，这主要得益于多种因素的共同作用。製药、生物技术和临床检查室对质谱、层析法和次世代定序等先进分析技术的日益普及，催生了对高效上游工程样本处理解决方案的稳定需求。癌症、糖尿病和心血管疾病等慢性病在全球范围内的日益流行，进一步加剧了对分子诊断的需求，凸显了样本製备的关键作用。此外，自动化技术的进步正在简化检查室工作流程，减少人为错误，并提昇科学研究和诊断机构的整体处理能力。个人化医疗和基因组学研究的蓬勃发展，也推动了全球医疗保健、製药和学术研究等各领域样本製备市场的成长。

由于多种因素，美国正崛起为样品製备市场的领先地区。其高度发展的生命科学生态系统，包括紧密的製药公司、生物技术公司和学术研究中心网络，正在持续推动对可靠样品製备解决方案的需求成长。对精准医疗和基因组学主导型研究计画的大量投资，正在加速临床和研究领域对先进样本製备设备和试剂盒的采用。联邦机构强制执行的监管标准要求严格的分析程序，鼓励在药物研发、食品安全检测和环境监测中使用标准化的样品製备和调查方法。美国国家癌症研究所 (NCI) 预测，到 2025 年，美国将新增约 200 万例癌症病例，这将持续推动对依赖高效样品製备的分子诊断和基因组分析工作流程的需求。随着实验室自动化在商业和学术研究环境中的持续加速应用，美国样品製备市场的前景仍然十分光明。

样品製备市场的发展趋势：

扩大实验室工作流程的自动化程度

全球样品製备市场正受到自动化技术快速融入实验室工作流程的影响。随着製药、生物技术和临床检查室扩大营运规模以满足日益增长的诊断和研究需求，人工样本处理正逐渐被自动化系统所取代，从而提升处理能力、可重复性和一致性。自动化平台在高通量实验室环境中变得至关重要，因为它们可以降低交叉污染的风险，最大限度地减少操作人员的差异，并实现多个样品的同步处理。智慧液体处理系统、萃取工作站和模组化自动化平台的开发显着扩展了实验室操作人员的能力。这些系统与数位连接解决方案的整合日益增强，从而实现了跨分散式实验室网路的远端监控、软体更新和数据追踪。人工智慧在自动化仪器中的日益普及，使得能够实现适应检体基质变化的自优化通讯协定。 2025年4月，凯杰公司宣布分阶段推出新一代自动化样品製备系统QIAsymphony Connect。该系统可同时处理多达 96 个检体，并具有增强的数位连接性和改进的自动化功能，适用于肿瘤学、基因组学和临床研究工作流程，进一步巩固了这些领域以自动化主导的成长轨迹。

製药和生物技术领域的扩张

製药和生物技术产业是推动全球样品製备市场发展的主要驱动力之一。随着新药发现、生物製药开发和个人化医疗的不断推进，对准确、可靠和标准化的样品製备的需求显着增长。分离、纯化和浓缩蛋白质、核酸和代谢物以进行下游分析的需求对药物开发过程至关重要，能够确保研究各个阶段的数据完整性和可重复性。作为现代生物製药研究基础的基因组学和蛋白​​质组学分析，需要精细的上游处理以维持样本品质并最大限度地减少分析干扰。严格的药物开发监管框架使得检验的样品製备通讯协定成为确保符合数据完整性标准的关键。随着液态生物检体和无细胞DNA提取技术的日益普及，新的非侵入性诊断领域正在涌现，对高精度样品製备提出了更高的要求。世界卫生组织（WHO）的数据显示，非传染性疾病约占全球死亡总数的74%，凸显了国际社会对先进分子诊断及其相关样本製备技术的迫切需求。

对环境和食品安全检测的需求日益增长

环境监测和食品安全检测范围的不断扩大是全球样品製备市场预测的关键驱动因素。随着全球监管机构收紧对污染物、农药、重金属和食源性病原体的容许限值，对高灵敏度和高可靠性分析方法的需求显着增长。水、土壤和空气颗粒等环境样本含有复杂的基质，需要在仪器分析前进行彻底的萃取、纯化和浓缩。同样，食品中过敏原、添加剂和假标记物的检测也需要精细的样品製备，以达到符合监管要求的灵敏度。固相萃取、分散固相萃取和QuEChERS调查方法的进步，扩展了环境和食品安全领域专业人员可用的分析工具。对小型化和高通量样品製备方法的需求日益增长，能够缩短处理时间并减少溶剂消耗，有助于实现成本效益和永续性目标。 2025年，新英格兰生物实验室（NEB®）宣布推出NEBNext低偏倚小RNA文库製备试剂盒，旨在减少定序结果中小RNA类型的偏倚表达。与市售其他试剂盒相比，这种新一代小RNA製备方法更快、偏倚更小，并且支援更广泛的起始样本量。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 调查方法

第三章执行摘要

第四章：引言

第五章：全球样品製备市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依产品划分

  • 样品製备装置
    • 主要部分
      • 提取系统
      • 工作站
      • 自动蒸发系统
      • 液体处理设备
      • 其他的
  • 消耗品
  • 样品製备试剂盒
    • 主要部分
      • 净化套件
      • 隔离试剂盒
      • 提取套件

第七章 市场区隔：依应用领域划分

  • 蛋白质体学
  • 基因组学
  • 表观基因
  • 其他的

第八章 市场区隔：依最终用户划分

  • 製药和生物技术公司
  • 食品饮料业
  • 研究机构和学术机构
  • 其他的

第九章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十章 SWOT 分析

第十一章：价值链分析

第十二章：波特五力分析

第十三章：价格分析

第十四章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Agilent Technologies Inc
    • Bio-Rad Laboratories, Inc.
    • Biotage
    • F. Hoffmann-La Roche Ltd
    • Hamilton Company
    • Norgen Biotek Corp.
    • PerkinElmer Inc.
    • Phenomenex Inc.（Danaher Corporation）
    • Qiagen NV
    • Restek Corporation
    • Tecan Trading AG
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: SR112026A6241

The global sample preparation market size was valued at USD 9.1 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 14.16 Billion by 2034, exhibiting a CAGR of 5.05% from 2026-2034. North America currently dominates the market, holding a market share of 30% in 2025. The region benefits from its robust pharmaceutical and biotechnology research and development (R&D) infrastructure, widespread adoption of advanced genomics and proteomics-driven workflows, the growing prevalence of chronic diseases requiring precise molecular diagnostics, and the strong concentration of leading life sciences enterprises and research institutions expanding the sample preparation market share.

The global sample preparation market is experiencing sustained growth driven by multiple converging forces. The increasing adoption of advanced analytical techniques, including mass spectrometry, chromatography, and next-generation sequencing across pharmaceutical, biotechnology, and clinical laboratories, is creating consistent demand for efficient upstream sample processing solutions. The rising global prevalence of chronic diseases, including cancer, diabetes, and cardiovascular disorders, is intensifying the demand for molecular diagnostics, underscoring the critical role of sample preparation. Furthermore, advancements in automation technologies are streamlining laboratory workflows, reducing human error, and enhancing throughput across research and diagnostic facilities. The surge in personalized medicine initiatives and genomics research is also supporting the sample preparation market growth across diverse healthcare, pharmaceutical, and academic research verticals worldwide.

The United States has emerged as a major region in the Sample Preparation market owing to many factors. The country's highly developed life sciences ecosystem, encompassing a dense network of pharmaceutical companies, biotechnology firms, and academic research centers, creates a consistent and growing demand for reliable sample preparation solutions. Significant investment in precision medicine and genomics-driven research programs has accelerated the adoption of advanced sample preparation instruments and kits across clinical and research settings. Regulatory standards enforced by federal agencies mandate rigorous analytical procedures, reinforcing the use of standardized sample preparation methodologies in drug development, food safety testing, and environmental monitoring. According to the National Cancer Institute (NCI), approximately 2 million new cancer diagnoses are expected in the United States in 2025, sustaining demand for molecular diagnostics and genomic profiling workflows that depend on effective sample preparation. The sample preparation market outlook in the United States remains highly positive as laboratory automation adoption continues to accelerate across both commercial and academic research environments.

SAMPLE PREPARATION MARKET TRENDS:

Expanding Automation in Laboratory Workflows

The global sample preparation market is significantly shaped by the rapid integration of automation into laboratory workflows. As pharmaceutical, biotechnology, and clinical laboratories scale their operations to meet growing diagnostic and research demands, manual sample processing is increasingly being replaced by automated systems that deliver enhanced throughput, reproducibility, and consistency. Automated platforms reduce the risk of cross-contamination, minimize operator-dependent variability, and enable simultaneous processing of multiple samples, making them indispensable in high-volume laboratory settings. The development of intelligent liquid handling systems, extraction workstations, and modular automation platforms has greatly expanded the capabilities available to laboratory operators. These systems are increasingly integrated with digital connectivity solutions, enabling remote monitoring, software updates, and data tracking across distributed laboratory networks. The growing adoption of artificial intelligence within automated instruments is enabling self-optimizing protocols that adapt to sample matrix variability. In April 2025, QIAGEN announced the phased launch of its next-generation QIAsymphony Connect automated sample preparation system, capable of processing up to 96 samples simultaneously with enhanced digital connectivity and improved automation capabilities for oncology, genomics, and clinical research workflows, reinforcing the trajectory of automation-led growth in the sector.

Pharmaceutical and Biotechnology Sector Expansion

The pharmaceutical and biotechnology sectors are among the primary drivers shaping the sample preparation market trends globally. As novel drug discovery, biologics development, and personalized medicine initiatives proliferate, the demand for accurate, reliable, and standardized sample preparation has intensified considerably. The need to isolate, purify, and concentrate proteins, nucleic acids, and metabolites for downstream analyses is fundamental to the drug development process, ensuring data integrity and reproducibility across all research stages. Genomic and proteomic profiling, which form the backbone of modern biopharmaceutical research, require meticulous upstream processing to maintain sample quality and minimize analytical interference. Stringent regulatory frameworks governing drug development necessitate validated sample preparation protocols that ensure compliance with data integrity standards. The increasing focus on liquid biopsy and cell-free DNA extraction is opening new frontiers for non-invasive diagnostics that demand precision-grade sample processing. According to the World Health Organization, non-communicable diseases account for approximately 74% of all deaths globally, elevating the international urgency for advanced molecular diagnostics and the sample preparation technologies that support their development.

Rising Environmental and Food Safety Testing Demands

The expanding scope of environmental monitoring and food safety testing is a critical driver of the global sample preparation market forecast. As regulatory agencies worldwide tighten permissible limits for contaminants, pesticides, heavy metals, and foodborne pathogens, the requirement for highly sensitive and reliable analytical methods has escalated substantially. Environmental samples such as water, soil, and air particulates involve complex matrices that necessitate thorough extraction, cleanup, and concentration before instrument-based analysis. Similarly, the detection of allergens, additives, and adulteration markers in food products demands meticulous sample preparation to achieve the sensitivity required for regulatory compliance. Advances in solid-phase extraction, dispersive solid-phase extraction, and QuEChERS methodologies have expanded the analytical toolkit available to professionals in environmental and food safety disciplines. The growing demand for miniaturized and high-throughput sample preparation formats is enabling faster turnaround times and lower solvent consumption, supporting both cost efficiency and sustainability goals. In 2025, New England Biolabs (NEB(R)) has announced the introduction of the NEBNext Low-bias Small RNA Library Prep Kit, aimed at reducing biased representation of small RNA types in sequencing results. This next generation method for preparing small RNA is quicker, less biased, and accommodates a wider input range compared to other kits available for purchase.

SAMPLE PREPARATION INDUSTRY SEGMENTATION:

Analysis by Product:

  • Sample Preparation Instruments
    • Extraction System
    • Workstation
    • Automated Evaporation System
    • Liquid Handling Instrument
    • Others
  • Consumables
  • Sample Preparation Kit
    • Purification Kit
    • Isolation Kit
    • Extraction Kit

Sample preparation Instruments holds 40% of the market share. Sample preparation instruments comprise the specialized equipment used to process, extract, purify, and transform biological and chemical specimens into analytically suitable formats across diverse laboratory applications. These instruments include extraction systems, liquid handling platforms, automated workstations, and evaporation units, each engineered to address specific stages of the sample processing workflow with precision and efficiency. The dominance of this segment is driven by the widespread integration of automation in laboratory environments, where instrument-based systems replace manual, time-intensive protocols, delivering enhanced throughput, consistency, and reproducibility. Pharmaceutical and biotechnology laboratories rely extensively on these instruments for nucleic acid extraction, protein isolation, and metabolite profiling fundamental to drug discovery and clinical research pipelines. The growing adoption of digitally connected and modular instrument platforms capable of interfacing with laboratory information management systems is further expanding their utility.

Analysis by Application:

  • Proteomics
  • Genomics
  • Epigenomics

Genomics leads the market with a share of 36%. Genomics represents the study, analysis, and sequencing of complete genetic material to understand structure, function, and evolution across organisms. As a primary application for sample preparation technologies, genomics encompasses DNA extraction, RNA isolation, library preparation for next-generation sequencing, and nucleic acid purification, all of which demand high-quality upstream specimen processing. The widespread adoption of genomics in drug discovery, disease diagnosis, agricultural biotechnology, and personalized medicine continues to propel demand for specialized sample preparation kits and instruments. Standardized and validated sample preparation protocols are essential to maintaining nucleic acid integrity and reproducibility in genomic analyses, directly influencing the reliability of downstream sequencing results. The integration of genomics into routine clinical diagnostics, including liquid biopsy and hereditary disease screening, is further expanding application scope. The expanding sample preparation market forecast reflects the increasing centrality of genomics across healthcare and research sectors globally.

Analysis by End User:

  • Pharmaceutical or Biotechnology Companies
  • Food and Beverages Industry
  • Research and Academic Institutes

Pharmaceutical or biotechnology companies dominates the market, with a share of 35%. Pharmaceutical and biotechnology companies represent the leading end-user segment in the sample preparation market, driven by their extensive reliance on robust, standardized sample processing workflows across every stage of the drug development lifecycle. From early-stage target identification and lead optimization to preclinical testing and clinical validation, these organizations require precise sample preparation to ensure the accuracy, reproducibility, and regulatory compliance of analytical data. The extraction and purification of proteins, nucleic acids, lipids, and small molecules are routine activities within pharmaceutical and biotechnology laboratories, where sample quality directly impacts the validity of research outcomes. Increasing investments in biologics development, gene therapies, and mRNA-based therapeutics are intensifying demand for specialized purification kits and automated preparation instruments capable of handling complex biological matrices.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America, accounting for 30% of the share, enjoys the leading position in the market. North America's leadership in the global sample preparation market is underpinned by a convergence of structural advantages, including the world's largest concentration of pharmaceutical and biotechnology companies, a highly developed academic research infrastructure, and strong federal funding for life sciences and genomics programs. The region's advanced laboratory ecosystem supports widespread adoption of automated sample preparation platforms enabling high-throughput processing essential for clinical diagnostics, drug development, and environmental monitoring. Regulatory requirements from agencies including the U.S. FDA and Health Canada ensure standardized sample preparation procedures are deeply embedded in the workflows of both commercial and academic laboratories. The growing emphasis on personalized medicine, proteomics-based diagnostics, and liquid biopsy applications further drives innovation and investment in sample preparation technologies throughout the region.

KEY REGIONAL TAKEAWAYS:

UNITED STATES SAMPLE PREPARATION MARKET ANALYSIS

The United States represents the most significant individual country market for sample preparation globally, characterized by the highest concentration of pharmaceutical and biotechnology enterprises, research universities, and government-funded genomics and precision medicine programs. The robust clinical laboratory infrastructure across the country supports high-volume testing for cancer screening, infectious disease diagnosis, and genetic counseling, all fundamentally underpinned by advanced sample preparation workflows. Growing adoption of next-generation sequencing in both research and clinical settings is generating sustained demand for nucleic acid extraction kits, liquid handling systems, and automated extraction platforms capable of processing large sample batches. Federal initiatives supporting genomics-based healthcare, administered through agencies including the National Institutes of Health and the National Cancer Institute, continue to fund research programs that directly stimulate sample preparation technology adoption across academic medical centers and commercial laboratories. The FDA's mandate for validated sample preparation procedures in pharmaceutical testing, diagnostics, and food safety creates a consistent and structured demand environment. In 2025, 2,041,910 new cancer cases and 618,120 cancer deaths are expected to take place in the United States., reinforcing the country's leading role in precision oncology and molecular diagnostics and driving sustained sample preparation market growth across clinical and research settings.

EUROPE SAMPLE PREPARATION MARKET ANALYSIS

Europe represents the second-largest regional market for sample preparation, supported by a sophisticated network of research institutions, pharmaceutical manufacturers, and academic laboratories distributed across the continent. The European life sciences sector benefits from well-established regulatory frameworks administered by the European Medicines Agency, which mandate standardized sample preparation in drug development and quality control processes. Significant national and cross-border investment in genomics and proteomics research, along with expanding clinical diagnostics networks, reinforces demand for high-quality sample preparation instruments and consumables. Countries including Germany, the United Kingdom, France, and Switzerland host major pharmaceutical research hubs where advanced analytical workflows are integral to daily operations. The continent's growing focus on precision medicine and aging population-driven healthcare demands are expanding the need for molecular diagnostics and associated sample preparation technologies. According to the European Commission's Horizon Europe research program, health research received an allocation of approximately EUR 8.246 billion across the program's operational period, with significant funding directed toward genomics, oncology research, and molecular diagnostics that drive adoption of advanced sample preparation technologies across European laboratories.

ASIA-PACIFIC SAMPLE PREPARATION MARKET ANALYSIS

Asia-Pacific is among the fastest-growing regional markets for sample preparation, propelled by rapid expansion in pharmaceutical manufacturing, biotechnology research, and clinical diagnostics infrastructure. Countries such as China, India, Japan, South Korea, and Australia are investing heavily in life sciences R&D, with government-backed innovation programs fueling laboratory equipment procurement. The increasing burden of chronic diseases and infectious illnesses is amplifying demand for molecular diagnostic tools that rely on effective sample preparation workflows. The growth of contract research organizations and pharmaceutical contract manufacturing organizations in the region is further accelerating adoption of automated sample preparation platforms. Union Budget 2026-27 suggested the Biopharma SHAKTI with a budget of Rs. 10,000 crores across five years, focused on enhancing India's framework for the manufacture of biologics and biosimilars, creating a growing pipeline for laboratory sample preparation technologies across research and manufacturing facilities in the country.

LATIN AMERICA SAMPLE PREPARATION MARKET ANALYSIS

Latin America is an emerging market for sample preparation, driven by growing investments in healthcare infrastructure, pharmaceutical production, and academic research across key economies including Brazil and Mexico. The rising burden of infectious diseases and chronic conditions such as cancer and diabetes is creating increased demand for molecular diagnostics and the sample preparation workflows that support them. Government healthcare reforms aimed at expanding diagnostic testing capacity are reinforcing laboratory equipment adoption across the region. Academic institutions and public health laboratories are increasingly seeking automated and kit-based sample preparation solutions to improve testing efficiency and data quality.

MIDDLE EAST AND AFRICA SAMPLE PREPARATION MARKET ANALYSIS

The Middle East and Africa represent an emerging market for sample preparation, driven by expanding healthcare investments and the growing establishment of diagnostic laboratories across the region. Government-led healthcare modernization programs in Gulf Cooperation Council countries and South Africa are creating new demand for laboratory automation and molecular diagnostics platforms. The increasing prevalence of infectious diseases and non-communicable conditions, along with the expansion of pharmaceutical manufacturing in selected markets, are further creating avenues for sample preparation adoption. Rising investments in academic and clinical research infrastructure are opening new opportunities for instrument and consumable procurement across public and private healthcare sectors.

COMPETITIVE LANDSCAPE:

The global sample preparation market is characterized by intense competition among a diverse group of established life sciences companies, specialty laboratory suppliers, and emerging technology providers. Key players are focused on product innovation, strategic mergers and acquisitions, and the development of integrated automation platforms that combine instruments with proprietary reagents and consumables to create comprehensive end-to-end sample preparation solutions. Competition is shaped by the ability to deliver validated, regulatory-compliant workflows that meet the evolving demands of pharmaceutical, clinical, and environmental laboratories. Leading companies are also leveraging digital connectivity, artificial intelligence, and cloud-based monitoring to differentiate their instrument platforms and drive customer retention through ecosystem lock-in. Strategic investments in emerging markets, particularly within the Asia-Pacific and Latin American regions, are intensifying as established players seek to capture growing laboratory infrastructure demand. The increasing convergence of sample preparation with advanced sequencing and diagnostics platforms is reshaping competitive boundaries and creating opportunities for cross-segment innovation partnerships across the market.

The report provides a comprehensive analysis of the competitive landscape in the sample preparation market with detailed profiles of all major companies, including:

  • Agilent Technologies Inc
  • Bio-Rad Laboratories, Inc.
  • Biotage
  • F. Hoffmann-La Roche Ltd
  • Hamilton Company
  • Norgen Biotek Corp.
  • PerkinElmer Inc.
  • Phenomenex Inc. (Danaher Corporation)
  • Qiagen N.V.
  • Restek Corporation
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the sample preparation market?

2. What is the future outlook of the sample preparation market?

3. What are the key factors driving the sample preparation market?

4. Which region accounts for the largest sample preparation market share?

5. Which are the leading companies in the global sample preparation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Sample Preparation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Sample Preparation Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Extraction System
      • 6.1.2.2 Workstation
      • 6.1.2.3 Automated Evaporation System
      • 6.1.2.4 Liquid Handling Instrument
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Sample Preparation Kit
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Purification Kit
      • 6.3.2.2 Isolation Kit
      • 6.3.2.3 Extraction Kit
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Proteomics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Genomics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Epigenomics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical or Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Food and Beverages Industry
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research and Academic Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bio-Rad Laboratories, Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biotage
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 F. Hoffmann-La Roche Ltd
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Hamilton Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Norgen Biotek Corp.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 PerkinElmer Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Phenomenex Inc. (Danaher Corporation)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Qiagen N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Restek Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Tecan Trading AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Waters Corporation
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Sample Preparation Market: Major Drivers and Challenges
  • Figure 2: Global: Sample Preparation Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Sample Preparation Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Sample Preparation Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Sample Preparation Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Sample Preparation Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Sample Preparation Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Sample Preparation (Sample Preparation Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Sample Preparation (Sample Preparation Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Sample Preparation (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Sample Preparation (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Sample Preparation (Sample Preparation Kit) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Sample Preparation (Sample Preparation Kit) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Sample Preparation (Proteomics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Sample Preparation (Proteomics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Sample Preparation (Genomics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Sample Preparation (Genomics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Sample Preparation (Epigenomics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Sample Preparation (Epigenomics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Sample Preparation (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Sample Preparation (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Sample Preparation (Pharmaceutical or Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Sample Preparation (Pharmaceutical or Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Sample Preparation (Food and Beverages Industry) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Sample Preparation (Food and Beverages Industry) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Sample Preparation (Research and Academic Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Sample Preparation (Research and Academic Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Sample Preparation (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Sample Preparation (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: North America: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: North America: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: United States: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: United States: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Canada: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Canada: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Asia-Pacific: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Asia-Pacific: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: China: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: China: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Japan: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Japan: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: India: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: India: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: South Korea: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: South Korea: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Australia: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Australia: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Indonesia: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Indonesia: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Others: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Others: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Europe: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Europe: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Germany: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Germany: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: France: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: France: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: United Kingdom: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: United Kingdom: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Italy: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Italy: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Spain: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Spain: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Russia: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Russia: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Latin America: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Latin America: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Brazil: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Brazil: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Mexico: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Mexico: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Others: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Others: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Middle East and Africa: Sample Preparation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Middle East and Africa: Sample Preparation Market: Breakup by Country (in %), 2025
  • Figure 78: Middle East and Africa: Sample Preparation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Global: Sample Preparation Industry: SWOT Analysis
  • Figure 80: Global: Sample Preparation Industry: Value Chain Analysis
  • Figure 81: Global: Sample Preparation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Sample Preparation Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Sample Preparation Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Sample Preparation Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Sample Preparation Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Sample Preparation Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Sample Preparation Market: Competitive Structure
  • Table 7: Global: Sample Preparation Market: Key Players